EP 2040751 A2 20090401 - COMBINATION THERAPY EMPLOYING LYMPHOTOXIN BETA RECEPTOR BINDING MOLECULES IN COMBINATION WITH SECOND AGENTS
Title (en)
COMBINATION THERAPY EMPLOYING LYMPHOTOXIN BETA RECEPTOR BINDING MOLECULES IN COMBINATION WITH SECOND AGENTS
Title (de)
KOMBINATIONSTHERAPIE MIT LYMPHOTOXIN BETA REZEPTOR-BINDUNGSMOLEKÜLEN IN KOMBINATION MIT SEKUNDÄREN MITTELN
Title (fr)
THÉRAPIE COMBINÉE UTILISANT DES MOLÉCULES DE LIAISON AU RÉCEPTEUR DE LA LYMPHOTOXINE BÊTA ASSOCIÉES AVEC D'AUTRES AGENTS
Publication
Application
Priority
- US 2007014051 W 20070615
- US 81435706 P 20060615
Abstract (en)
[origin: WO2007146414A2] This invention features combination therapies that include a composition that activates lymphotoxin-beta receptor signaling in combination with one or more other biologic agents, as well as therapeutic methods.
IPC 8 full level
A61K 39/395 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07K 16/22 (2013.01 - EP US); C07K 16/2866 (2013.01 - EP US); A61K 2039/507 (2013.01 - EP US)
Citation (search report)
See references of WO 2007146414A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007146414 A2 20071221; WO 2007146414 A3 20080124; AU 2007258189 A1 20071221; CA 2655411 A1 20071221; EP 2040751 A2 20090401; JP 2009539999 A 20091119; US 2009175862 A1 20090709
DOCDB simple family (application)
US 2007014051 W 20070615; AU 2007258189 A 20070615; CA 2655411 A 20070615; EP 07796155 A 20070615; JP 2009515510 A 20070615; US 33026908 A 20081208